Neutralizing Antibodies Against a Specific Human Immunodeficiency Virus gp41 Epitope are Associated With Long-term Non-progressor Status

Abstract : Antibodies (Abs) play a central role in human immunodeficiency virus (HIV) protection due to their multiple functional inhibitory activities. W614A-3S Abs recognize a specific form of a highly conserved motif of the gp41 envelope protein and can elicit viral neutralization to protect CD4 + T cells. Here, we describe in detail the neutralizing profile of W614A-3S Abs in untreated long-term non-progressor (LTNP) HIV-infected patients. W614A-3S Abs were detected in 23.5% (16/68) of untreated LTNP patients compared with b5% (5/104) of HIV-1 progressor patients. The W614A-3S Abs had efficient neutralizing activity that inhibited transmitted founder primary viruses and exhibited Fc-mediated inhibitory functions at low concentrations in primary monocyte-derived macrophages. The neutralizing capacity of W614A-3S Abs was inversely correlated with viral load (r = − 0.9013; p b 0.0001), viral DNA (r = − 0.7696; p = 0.0005) and was associated the preservation of high CD4 + T-cell counts and T-cell responses. This study demonstrates that W614A-3S neutralizing Abs may confer a crucial advantage to LTNP patients. These results provide insights for both pathophysiological research and the development of vaccine strategies.
Type de document :
Article dans une revue
EBioMedicine, Elsevier, 2017, 22, pp.122-132. 〈10.1016/j.ebiom.2017.07.007〉
Liste complète des métadonnées

Littérature citée [60 références]  Voir  Masquer  Télécharger

http://hal.upmc.fr/hal-01599388
Contributeur : Gestionnaire Hal-Upmc <>
Soumis le : lundi 2 octobre 2017 - 11:12:31
Dernière modification le : jeudi 11 janvier 2018 - 06:25:43

Fichier

1-s2.0-S2352396417302797-main....
Publication financée par une institution

Identifiants

Collections

Citation

Olivier Lucar, Bin Su, Valérie Potard, Assia Samri, Brigitte Autran, et al.. Neutralizing Antibodies Against a Specific Human Immunodeficiency Virus gp41 Epitope are Associated With Long-term Non-progressor Status. EBioMedicine, Elsevier, 2017, 22, pp.122-132. 〈10.1016/j.ebiom.2017.07.007〉. 〈hal-01599388〉

Partager

Métriques

Consultations de la notice

23

Téléchargements de fichiers

11